• Facebook
  • X
  • Instagram
  • RSS
  • Advertise
  • TradeIQ Concert
  • Research Reports
  • Heatmap
  • Billionaires
  • Entrepreneurs
  • Fintech
  • Banking
  • Gold & Metals
  • Real Estate
  • Crypto Press Release
0 Items
Trade Brains
  • Indian Markets
    • Editors Pick
    • Bulk/Block Deals
    • Corporate Action
    • Large-cap
    • Mid-cap
    • Micro-Penny
    • Recent Orders
    • Results
    • IPO Analysis
    • FPO Analysis
    • Stock Ideas
    • Technical
  • Global Markets
    • US Markets
    • Trump News
    • Asian Markets
    • European Markets
  • Digital Assets
    • Crypto
    • NFT
  • Business
    • Billionaires
    • Entrepreneurs
    • Fintech
    • Innovation
    • Leadership
    • Startups
  • Money
    • Gold & Metals
    • Banking
    • Credit Card
    • Mutual Funds
    • ETFs
    • Hedge Funds
    • Insurances
    • Real Estate
    • Retirement
    • Personal Finance
  • Lifestyle
  • Sports
Select Page

Stock under ₹100 hits 10% upper circuit after selling shares worth ₹134 Cr in PNB MetLife

by Trade Brains | April 3, 2025 11:07 am

A stock trading under Rs.100 surged to its 10 percent upper circuit after the company sold shares worth Rs.134.37 crores in PNB MetLife India Insurance. The transaction, involving 1,63,87,424 equity shares, attracted strong market interest, driving the stock’s sharp upward movement.

Price Variation

During Thursday’s trading session, shares of Elpro International Ltd hit its upper circuit limit of Rs.81.99 per share, rising 10 percent from their previous closing price of Rs.74.54 per share. However, the shares have retreated since then, trading at Rs.80.58 apiece. Over the past five years, the stock has delivered over 158 percent returns. 

What Happened 

Elpro International Limited has sold its entire remaining shareholding in PNB MetLife India Insurance Company Limited. The transaction involved the sale of 1,63,87,424 equity shares, each having a face value of Rs.10. The total value of the sale amounted to Rs.134.37 crores. 

This move marks the complete exit of Elpro International Limited from its investment in PNB MetLife. The sale was executed at a significant valuation, reflecting the company’s strategic decision to liquidate its holdings in the insurance firm.

Also read: Wockhardt & 4 other pharma stocks to benefit as CDMO market is expected to grow to $300 billion by 2028

Financial Overview

In its recent financial update, Elpro International Ltd reported consolidated revenue of Rs.16.35 crores for Q3 FY25, reflecting a 72 percent decrease compared to Rs.57.88 crores in Q3 FY24. Moreover, the company reported a net loss of Rs.21.07 crores in Q3 FY25, from a net profit of Rs.23.72 crores posted during the same period last year. 

Ratio Analysis

The company has a Return on Capital Employed (ROCE) of 7.34 percent and a Return on Equity (ROE) of 6.26 percent. Its Price-to-Earnings (P/E) ratio stands at 15.27, lower than the industry average of 28.41. Furthermore, the company maintains a current ratio of 3.22, a debt-to-equity ratio of 0.33, and an Earnings Per Share (EPS) of Rs.4.88. 

Business Overview

Elpro International Limited, founded in 1962, is a publicly traded company based in Mumbai, India. It operates in various industries, including electrical equipment manufacturing, real estate, investments, and renewable energy through windmills. The company was established in partnership with General Electric (GE), USA, and is known for its expertise in surge protection technology and zinc oxide disc production using GE’s globally recognized technology.

Written by – Siddesh S Raskar

Disclaimer

The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.

Candlesticks and chart trading mastery

Search Topic or Keyword

Easiest Stock Screener Tool!

Best stock discovery tool with +130 filters, built for fundamental analysis. Profitability, Growth, Valuation, Liquidity, and many more filters. Search Stocks Industry-wise, Export Data For Offline Analysis, Customizable Filters.

  • — Stock Screener
  • — Compare Stocks
  • — Stock Buckets
  • — Portfolio Backtesting

Start your stock analysis journey with Trade Brains Portal today. Launch here!

Keep the Learning On!

Subscribe to Youtube to watch our latest stock market videos. Subscribe here.

About Trade Brains

Trade Brains is India’s trusted financial and business news portal.

Phone: 080884 91790

Email: [email protected]

Quick Links

  • Trade Brains Portal
  • Stock Screener
  • Compare Stocks
  • Trade Brains News
  • Candlesticks Books
  • Fingrad
  • Subscribe on Youtube

Contact and Partnership

Reach us out at

  • Phone: [+91] 8088491790
  • Email: [email protected]

For Advertisement, Press Releases, Partnerships or to get backlinks on this website, please e-mail us at [email protected]

For Partnerships & Promotio

Visit  – tradebrainsawards.com/

Chandan Singh Rawat
Emaill: [email protected]
Mob: (+91)6366648573

Bikram Singhary
Email: [email protected]
Mob: (+91)8088491790

Other Links

  • Upcoming Dividend Stocks
  • Upcoming Bonus Issue
  • Nifty 50 Heatmap
  • Stock Research Reports
  • Trending Stocks Today
  • Stock Comapre
  • Newsslash

 

 

  • About
  • Careers
  • Advertise & Backlinks
  • Terms and Conditions
  • Disclaimer & Privacy Policy
  • Contact
  • Submit Press Release
  • Facebook
  • X
  • Instagram
  • RSS
2025 © Tradebrains Technologies Pvt Ltd - All Right Reserved